NXTCL — NextCell Pharma AB Share News
0.000.00%
Last trade - 00:00- SEK126.39m
- SEK94.06m
- SEK13.70m
Brief: NextCell To Present Status Of Ongoing Clinical Trial At Nordic Life Science Days
Brief: NextCell Applies For Prediction Methodology Patent
Brief: NextCell Pharma gets Approva; The Usage Of High-Dose Protrans In The Ongoing Clinical Trial
Brief: Extended Tissue Establishment Authorization
Brief: Nextcell Enters Into Memorandum Of Agreement With China General Consulting & Investment Co
Brief: NextCell Pharma: Nordic Tech House To Invest In Company
Brief: Nextcell Pharma Files Patent Application
Brief: Nextcell Pharma Q4 loss widens to SEK 4.8 mln
Brief: Nextcell Pharma Q3 pre-tax loss widens to SEK 3.6 mln